B/BE/25/BVW3 - Fiche d'information destinée au public (préparée par le notifiant)

File: 
Icône PDF bbe25bvw3_pub_fr.pdf
Trial reference: 
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) with Severe or Moderately Severe Hemophilia B
Doc type: 
Information for the public